Gilead's hopeful Covid-19 drug appears to do well in 2 key clinical trials

Study results appear to back up anecdotal evidence from doctors in Italy and China.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.